Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature
  • Letter
  • Published:

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Naturevolume 441, pages235–238 (2006)Cite this article

Abstract

On activation, T cells undergo distinct developmental pathways, attaining specialized properties and effector functions. T-helper (TH) cells are traditionally thought to differentiate into TH1 and TH2 cell subsets. TH1 cells are necessary to clear intracellular pathogens and TH2 cells are important for clearing extracellular organisms1,2. Recently, a subset of interleukin (IL)-17-producing T (TH17) cells distinct from TH1 or TH2 cells has been described and shown to have a crucial role in the induction of autoimmune tissue injury3,4,5. In contrast, CD4+CD25+Foxp3+ regulatory T (Treg) cells inhibit autoimmunity and protect against tissue injury6. Transforming growth factor-β (TGF-β) is a critical differentiation factor for the generation of Treg cells7. Here we show, using mice with a reporter introduced into the endogenousFoxp3 locus, that IL-6, an acute phase protein induced during inflammation8,9, completely inhibits the generation of Foxp3+ Treg cells induced by TGF-β. We also demonstrate that IL-23 is not the differentiation factor for the generation of TH17 cells. Instead, IL-6 and TGF-β together induce the differentiation of pathogenic TH17 cells from naive T cells. Our data demonstrate a dichotomy in the generation of pathogenic (TH17) T cells that induce autoimmunity and regulatory (Foxp3+) T cells that inhibit autoimmune tissue injury.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscription info for Japanese customers

We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

￥ 4,980

Prices may be subject to local taxes which are calculated during checkout

Figure 1:Inhibition of Treg development by different cytokines.
Figure 2:Cytokines required for the generation of TH17 cells.
Figure 3:Reciprocal expression of Foxp3 and IL-17 in T cells during differentiation.
Figure 4:Enhanced IL-17 production by T cells and CNS autoimmunity in TGF-β transgenic mice.

Similar content being viewed by others

References

  1. Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.Annu. Rev. Immunol.7, 145–173 (1989)

    Article CAS PubMed  Google Scholar 

  2. Bottomly, K. A functional dichotomy in CD4+ T lymphocytes.Immunol. Today9, 268–274 (1988)

    Article CAS PubMed  Google Scholar 

  3. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.J. Exp. Med.201, 233–240 (2005)

    Article CAS PubMed PubMed Central  Google Scholar 

  4. Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nature Immunol.6, 1123–1132 (2005)

    Article CAS  Google Scholar 

  5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.Nature Immunol.6, 1133–1141 (2005)

    Article CAS  Google Scholar 

  6. Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses.Annu. Rev. Immunol.22, 531–562 (2004)

    Article CAS PubMed  Google Scholar 

  7. Chen, W. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3.J. Exp. Med.198, 1875–1886 (2003)

    Article CAS PubMed PubMed Central  Google Scholar 

  8. Hirano, T. Interleukin 6 and its receptor: ten years later.Int. Rev. Immunol.16, 249–284 (1998)

    Article CAS PubMed  Google Scholar 

  9. Ozato, K., Tsujimura, H. & Tamura, T. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.Biotechniques33 (Suppl.), S66–S68 (2002)

    Article  Google Scholar 

  10. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3.Science299, 1057–1061 (2003)

    Article ADS CAS PubMed  Google Scholar 

  11. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.Nature Immunol.4, 330–336 (2003)

    Article CAS  Google Scholar 

  12. Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells.Nature Immunol.4, 337–342 (2003)

    Article CAS  Google Scholar 

  13. Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.J. Exp. Med.197, 1073–1081 (2003)

    Article CAS PubMed PubMed Central  Google Scholar 

  14. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.J. Biol. Chem.278, 1910–1914 (2003)

    Article CAS PubMed  Google Scholar 

  15. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R.J. Immunol.168, 5699–5708 (2002)

    Article CAS PubMed  Google Scholar 

  16. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supportsde novo differentiation of IL-17-producing T cells.Immunity24, 179–189 (2006)

    Article CAS PubMed  Google Scholar 

  17. Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology.Nature Rev. Immunol.2, 46–53 (2002)

    Article CAS  Google Scholar 

  18. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease.Nature359, 693–699 (1992)

    Article ADS CAS PubMed PubMed Central  Google Scholar 

  19. Nardelli, D. T. et al. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis inBorrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.Clin. Diagn. Lab. Immunol.11, 1075–1084 (2004)

    CAS PubMed PubMed Central  Google Scholar 

  20. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.J. Immunol.161, 6480–6486 (1998)

    CAS PubMed  Google Scholar 

  21. Okuda, Y. et al. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35–55 induced experimental autoimmune encephalomyelitis.J. Neuroimmunol.101, 188–196 (1999)

    Article CAS PubMed  Google Scholar 

  22. Okuda, Y., Sakoda, S., Saeki, Y., Kishimoto, T. & Yanagihara, T. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein.J. Neuroimmunol.105, 120–123 (2000)

    Article CAS PubMed  Google Scholar 

  23. Eugster, H. P. et al. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway.Eur. J. Immunol.31, 2302–2312 (2001)

    Article CAS PubMed  Google Scholar 

Download references

Acknowledgements

We thank R. A. Sobel for histological analysis of CNS tissues from mice, D. Kozoriz for cell sorting, and A. Jäger for technical assistance. This work was supported by grants from the National Multiple Sclerosis Society, the National Institutes of Health, JDRF Center for Immunological Tolerance at Harvard and the Deutsche Forschungsgemeinschaft.

Author information

Author notes

  1. Estelle Bettelli, Yijun Carrier and Wenda Gao: *These authors contributed equally to this work

Authors and Affiliations

  1. Center for Neurologic Diseases, Brigham and Women's Hospital,

    Estelle Bettelli, Yijun Carrier, Thomas Korn, Howard L. Weiner & Vijay K. Kuchroo

  2. Transplant Research Center, Beth Israel Hospital, Harvard Medical School, Boston, 77 Avenue Louis Pasteur, Massachusetts, 02115, USA

    Wenda Gao & Terry B. Strom

  3. Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Cambridge, 65 Landsdowne Street, Massachusetts, 02139, USA

    Mohamed Oukka

Authors
  1. Estelle Bettelli
  2. Yijun Carrier
  3. Wenda Gao
  4. Thomas Korn
  5. Terry B. Strom
  6. Mohamed Oukka
  7. Howard L. Weiner
  8. Vijay K. Kuchroo

Corresponding authors

Correspondence toMohamed Oukka orVijay K. Kuchroo.

Ethics declarations

Competing interests

Reprints and permissions information is available atnpg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Figure 1

Induction of Th-IL-17 cells by activation of naive CD4+ T cells with plate bound anti-CD3 plus anti-CD28 in the presence of TGF-β and IL-6. (PDF 462 kb)

Supplementary Figure 2

IL-6 deficient mice are resistant to the development of EAE and fail to generate Th-IL-17 cells. (PDF 520 kb)

Supplementary Figure Legends

Text to accompany the above Supplementary Figures (DOC 20 kb)

Supplementary Table 1

Histological Analysis of the CNS from 2D2 and 2D2xTg TGF-b with EAE (XLS 17 kb)

Supplementary Methods

This file contains additional details on the methods used in this study. (DOC 30 kb)

Rights and permissions

About this article

Cite this article

Bettelli, E., Carrier, Y., Gao, W.et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature441, 235–238 (2006). https://doi.org/10.1038/nature04753

Download citation

This article is cited by

Access through your institution
Buy or subscribe

Associated content

Collection

Nobel Prize in Physiology or Medicine 2025

What does it mean to be just 17?

  • Cristina M. Tato
  • John J. O'Shea
NatureNews & Views

Advertisement

Search

Advanced search

Quick links

Nature Briefing

Sign up for theNature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox.Sign up for Nature Briefing
[8]ページ先頭
©2009-2026 Movatter.jp